Mitigation of Health Effects in Older Adults With Hypertension by Reducing Exposure to Hea
The goal of this clinical trial is to assess the effectiveness of an intervention (combination of behavioural recommendations and technical measures) in reducing personal exposure to heat and air pollution and related health effects in older adults with hypertension. The main questions it aims to answer are: * Does the
| Condition(s) | Hypertension Arterial, 65 Years Older |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this clinical trial is to assess the effectiveness of an intervention (combination of behavioural recommendations and technical measures) in reducing personal exposure to heat and air pollution and related health effects in older adults with hypertension. The main questions it aims to answer are: * Does the intervention (combination of behavioral recommendations for heat mitigation) reduce personal ambient temperature exposure, measured using a wearable device (iButton)? * Does the intervention (combination of behavioral recommendations for air pollution mitigation and use of indoor air cleaners) reduce indoor exposure to air pollution, measured using indoor air quality sensors (Purple Air)? * Does the intervention (combination of behavioral recommendations for heat mitigation) |
| Who can participate | Inclusion Criteria: * Aged ≥65 years * Living in Barcelona (Spain) or Nicosia (Cyprus) metropolitan areas * Have a physician's diagnosis of arterial hypertension * Receive daily anti-hypertensive medication * Clinically stable Exclusion Criteria: * Currently smoking * Presence of any smoking residents in the household * Not residing at the household for at least 5 days a week * Planning to move from the current home within the next two months * No access to Wi-Fi or 4G/5G mobile phone * Severe chronic conditions (congestive heart failure, ischemic heart disease, significant valvular heart disease, diabetes mellitus type 2 (DM2), inflammatory diseases, renal failure, or active cancer) * Illicit drugs abuse * Alcohol abuse * Psychiatric disorders * Severe mental disability that interferes wi |
| Ages | 65 Years |
| Sex | All |
| Lead sponsor | University of Cyprus |
| Locations | Nicosia, Cyprus; Barcelona, Spain |
| Start date | 2026-05-01 |
| NCT ID | NCT07606859 |
| Official listing | https://clinicaltrials.gov/study/NCT07606859 |